TONIX PHARMACEUTICALS HOLDING CORP. Other Non-Current Assets
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) had Other Non-Current Assets of $4.55 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-10
- 2026-06-30: Other Assets, Noncurrent $4.55M.
- 2026-03-31: Other Assets, Noncurrent $4.29M.
- 2025-12-31: Other Assets, Noncurrent $2.29M; Other Assets, Noncurrent as first filed $2.17M.
- 2025-09-30: Other Assets, Noncurrent $1.30M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $4.55M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $4.29M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $2.29M 10-Q · filed 2026-08-10 | $2.17M 10-K · filed 2026-03-12 |
| 2025-09-30 | $1.30M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $931.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $910.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $951.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $951.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $961.00K 10-Q · filed 2024-08-16 | |
| 2024-03-31 | $960.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $1.13M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $1.05M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $292.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $385.00K 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $264.00K 10-K · filed 2024-04-01 | $384.00K 10-K · filed 2023-03-13 |
| 2022-09-30 | $360.00K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $379.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $379.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $379.00K 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |